Ind-Swift Laboratories Ltd. (INDSWFTLAB)
Market Closed
10 Aug, 10:00
XNSE XNSE Primary MSE ₹
237. 24
+8.83
+3.8659%
₹
11.98B Market Cap
16.44 P/E Ratio
- Div Yield
1.03M Volume
0 Eps
₹ 228.41
Previous Close Want to track INDSWFTLAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
INDSWFTLAB closed today higher at ₹237.24, an increase of 3.8659% from yesterday's close, completing a monthly increase of 16.3226% or ₹33.29. Over the past 12 months, INDSWFTLAB stock gained 165.8449%.
INDSWFTLAB is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
INDSWFTLAB Chart
People also search for
Ind-Swift Laboratories Ltd. (INDSWFTLAB) FAQ
What is the stock price today?
The current price is ₹237.24.
On which exchange is it traded?
Ind-Swift Laboratories Ltd. is listed on XNSE.
What is its stock symbol?
The ticker symbol is INDSWFTLAB.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 11.98B.
Has Ind-Swift Laboratories Ltd. ever had a stock split?
No, there has never been a stock split.
Ind-Swift Laboratories Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Navrattan R. Munjal CEO | XNSE Exchange | Y3990X106 CUSIP |
| IN Country | 1,246 Employees | 20 Sep 2011 Last Dividend | - Last Split | - IPO Date |
Overview
Ind-Swift Laboratories Limited is a prominent entity in the pharmaceutical sector, primarily focused on the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Established in 1995, the company has its roots in Manimajra, India, and has expanded its reach by exporting its products to various global markets. Its comprehensive portfolio spans across multiple therapeutic areas, catering to diverse medical needs and fostering advancements in healthcare.
Products and Services
Ind-Swift Laboratories Limited offers a varied range of products and services, detailed as follows:
- APIs in Various Therapeutic Areas: The company provides active pharmaceutical ingredients effective in treating conditions such as cardiovascular diseases, diabetes, psychotic disorders, bone diseases, migraines, Parkinson's disease, and many others. These APIs cover a wide spectrum of medical needs, from antihistamines and analgesics to treatments for ADHD and antineoplastic conditions.
- Reference Standards and Impurities: With a focus on quality and precision, Ind-Swift manufactures reference standards and impurities for a multitude of APIs like acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, and many more. These materials are crucial for the pharmaceutical industry to ensure the purity, strength, and quality of pharmaceutical products.
- Contract Research and Manufacturing Services: Beyond its product offerings, Ind-Swift engages in contract research and manufacturing services, providing comprehensive solutions from research and development to manufacturing. This enables other pharmaceutical companies to leverage Ind-Swift's expertise and facilities for their product development and production needs.
Contact Information
Address: Shivalik Enclave, Manimajra, India, 160101
Phone: 91 17 2506 1850
Website: https://www.indswiftlabs.com
